Contribution of β‐adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and β3‐adrenoceptor knockout mice
Authors:
- 1 June 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (4) , 747-758
Abstract
The smooth muscle relaxant responses to the mixed β3‐, putative β4‐adrenoceptor agonist, (−)‐CGP 12177 in rat colon are partially resistant to blockade by the β3‐adrenoceptor antagonist SR59230A suggesting involvement of β3‐ and putative β4‐adrenoceptors. We now investigated the function of the putative β4‐adrenoceptor and other β‐adrenoceptor subtypes in the colon, oesophagus and ureter of wildtype (WT) and β3‐adrenoceptor knockout (β3KO) mice. (−)‐Noradrenaline and (−)‐adrenaline relaxed KCl (30 mM)‐precontracted colon mostly through β1‐and β3‐adrenoceptors to a similar extent and to a minor extent through β2‐adrenoceptors. In colon from β3KO mice, (−)‐noradrenaline was as potent as in WT mice but the effects were mediated entirely through β1‐adrenoceptors. (−)‐CGP 12177 relaxed colon from β3KO mice with 2 fold greater potency than in WT mice. The maintenance of potency for (−)‐noradrenaline and increase for (−)‐CGP 12177 indicate compensatory increases in β1‐ and putative β4‐adrenoceptor function in β3KO mice. In oesophagi precontracted with 1 μM carbachol, (−)‐noradrenaline caused relaxation mainly through β1‐and β3‐adrenoceptors. (−)‐CGP 12177 (2 μM) relaxed oesophagi from WT by 61.4±5.1% and β3KO by 67.3±10.1% of the (−)‐isoprenaline‐evoked relaxation, consistent with mediation through putative β4‐adrenoceptors. In ureter, (−)‐CGP 12177 (2 μM) reduced pacemaker activity by 31.1±2.3% in WT and 31.3±7.5% in β3KO, consistent with mediation through putative β4‐adrenoceptors. Relaxation of mouse colon and oesophagus by catecholamines are mediated through β1‐ and β3‐adrenoceptors in WT. The putative β4‐adrenoceptor, which presumably is an atypical state of the β1‐adrenoceptor, mediates the effects of (−)‐CGP 12177 in colon, oesophagus and ureter. British Journal of Pharmacology (2000) 130, 747–758; doi:10.1038/sj.bjp.0703365Keywords
This publication has 35 references indexed in Scilit:
- Putative β4‐adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (−)‐[3H]‐CGP 12177 bindingBritish Journal of Pharmacology, 1999
- Action potential shortening through the putative β4‐adrenoceptor in ferret ventricle: comparison with β1‐ and β2‐adrenoceptor‐mediated effectsBritish Journal of Pharmacology, 1998
- Metabolic response to various β‐adrenoceptor agonists in β3‐adrenoceptor knockout mice: Evidence for a new β‐adrenergic receptor in brown adipose tissueBritish Journal of Pharmacology, 1998
- Validity of (−)‐[3H]‐CGP 12177A as a radioligand for the ‘putative β4‐adrenoceptor’ in rat atriumBritish Journal of Pharmacology, 1998
- Lipolytic effects of conventional β3‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β4‐adrenoceptorBritish Journal of Pharmacology, 1997
- Targeted gene disruption reveals a leptin-independent role for the mouse beta3-adrenoceptor in the regulation of body composition.Journal of Clinical Investigation, 1997
- Four β-adrenoceptor subtypes in the mammalian heartTrends in Pharmacological Sciences, 1997
- Effects of (−)‐RO363 at human atrial β‐adrenoceptor subtypes, the human cloned β3‐adrenoceptor and rodent intestinal β3‐adrenoceptorsBritish Journal of Pharmacology, 1997
- Anomalous Behavior of CGP 12177A ON β2-Adrenergic ReceptorsJournal of Receptors and Signal Transduction, 1996
- Is there a third heart β-adrenoceptor?Trends in Pharmacological Sciences, 1989